- Home
- IRT vs AXSM Comparison
IRT vs AXSM Comparison
Compare IRT & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRT
- AXSM
- Stock Information
- Founded
- IRT 2009
- AXSM 2012
- Country
- IRT United States
- AXSM United States
- Employees
- IRT N/A
- AXSM N/A
- Industry
- IRT Real Estate Investment Trusts
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- IRT Real Estate
- AXSM Health Care
- Exchange
- IRT Nasdaq
- AXSM Nasdaq
- Market Cap
- IRT 4.4B
- AXSM 4.0B
- IPO Year
- IRT 2013
- AXSM 2015
- Fundamental
- Price
- IRT $20.82
- AXSM $93.42
- Analyst Decision
- IRT Buy
- AXSM Strong Buy
- Analyst Count
- IRT 8
- AXSM 14
- Target Price
- IRT $19.25
- AXSM $124.57
- AVG Volume (30 Days)
- IRT 2.0M
- AXSM 436.2K
- Earning Date
- IRT 10-28-2024
- AXSM 11-04-2024
- Dividend Yield
- IRT 3.11%
- AXSM N/A
- EPS Growth
- IRT N/A
- AXSM N/A
- EPS
- IRT N/A
- AXSM N/A
- Revenue
- IRT $650,102,000.00
- AXSM $291,489,000.00
- Revenue This Year
- IRT N/A
- AXSM $42.50
- Revenue Next Year
- IRT $3.79
- AXSM $69.28
- P/E Ratio
- IRT N/A
- AXSM N/A
- Revenue Growth
- IRT 0.55
- AXSM 59.73
- 52 Week Low
- IRT $11.61
- AXSM $55.02
- 52 Week High
- IRT $20.87
- AXSM $98.40
- Technical
- Relative Strength Index (RSI)
- IRT 65.51
- AXSM 61.39
- Support Level
- IRT $19.67
- AXSM $89.54
- Resistance Level
- IRT $20.87
- AXSM $96.56
- Average True Range (ATR)
- IRT 0.36
- AXSM 2.97
- MACD
- IRT 0.00
- AXSM 0.02
- Stochastic Oscillator
- IRT 95.42
- AXSM 62.04
About IRT Independence Realty Trust Inc.
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.